3 things to know about the NanoFuse Bioactive Matrix

NanoFUSE Biologics will attend the 2018 International Meeting on Advanced Spine Techniques in Los Angeles between July 11 and July 14.

Advertisement

Here are three things to know about the NanoFUSE Bioactive Matrix:

1. It is the only FDA-cleared bioglass and demineralized bone matrix combination product.

2. The NanoFUSE Bioactive Matrix is used with autograft as a bone graft extender in the posterolateral spine.

3. NanoFUSE DBM is designed to be moldable, extrudable and to resist migration during irrigation.

More articles on biologics:

SpineMark enters strategic partnership with Regenexx to boost biologic options, patient volume: 4 key points

NanoFuse Biologics adds orthobiologics executive: 3 insights

Connect Healthcare Collaboration selects Regenexx as solution to lower employers’ orthopedic surgery costs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.